Answers · Views and frameworks

Why have Zhipu and MiniMax shares slumped in Hong Kong, and is listing still worth it for Chinese model companies?

FutureX's view: the main cause is a model-layer price war compressing the premium, not listing itself being wrong. Model companies cannot hold value, and a listing simply reflects that faster.

About nine months after listing, MiniMax fell below its HK$165 offer price in late October, and founder Yan Junjie's net worth dropped more than HK$90 billion from its peak. Zhipu (02513) fell about 84% from its peak and on November 10 announced a buyback of up to HK$4 billion in H shares. Together the two lost about $120 billion from their peaks.

Sources: Caixin Global (2026-10-23) and Bloomberg, MiniMax below offer price; BigGo Finance (2026-10-22, 10-23), HK$165 offer price, net worth down over HK$90 billion; MLQ.ai (2026-11-10), Zhipu down 84% from peak, buyback up to HK$4 billion; FourWeekMBA (2026-11-17), $120 billion lost combined (reported).

It was not only the two. Bloomberg reported in October that Chinese model stocks had lost about $150 billion combined. The reason is simple: open-source models and price wars keep making each call cheaper, and revenue cannot keep up with valuation. At the same time Anthropic listed at $1.5 trillion with revenue reportedly about 63 times theirs, which sharpens the contrast.

Sources: Bloomberg (2026-10-22), Chinese model stocks lost $150 billion; FourWeekMBA (2026-11-03), 63x revenue (reported); Reuters (2026-11-18), Anthropic at $1.5 trillion. FutureX does not hold Zhipu or MiniMax; not buy or sell advice.

Thesis · Value lands in applications and open-source chokepoints →Thesis · Open source resets the cost curve →Report · Open Models Near the Frontier at 1/40th the Price, Making AI Sovereignty Institution-Scale →

Related answers

FutureX core theses

All theses →

Updated 2026-11-19. Facts and examples come from FutureX Capital's published research, public talks, and public reporting, graded per our site-wide standard (verified / reported / per company disclosure). Nothing here is investment advice or an offer.